2-(4-methoxyphenyl)-1-methyl-6-phenyl-7-pyridin-4-yl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole
C31H23F3N4O — CID 118710919
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-methoxyphenyl)-1-methyl-6-phenyl-7-pyridin-4-yl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole
2-(4-methoxyphenyl)-1-methyl-6-phenyl-7-pyridin-4-yl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole (PubChem CID 118710919) has the molecular formula C31H23F3N4O and a molecular weight of 524.55 g/mol. Its IUPAC name is 2-(4-methoxyphenyl)-1-methyl-6-phenyl-7-pyridin-4-yl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole.
Molecular Properties
| Compound Name | 2-(4-methoxyphenyl)-1-methyl-6-phenyl-7-pyridin-4-yl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole |
|---|---|
| PubChem CID | 118710919 |
| Molecular Formula | C31H23F3N4O |
| Molecular Weight | 524.55 g/mol |
| Exact Mass | 524.18 |
| IUPAC Name | 2-(4-methoxyphenyl)-1-methyl-6-phenyl-7-pyridin-4-yl-3-[4-(trifluoromethyl)phenyl]imidazo[2,1-e]pyrazole |
| SMILES | COc1ccc(-c2c(-c3ccc(C(F)(F)F)cc3)n3nc(-c4ccccc4)c(-c4ccncc4)c3n2C)cc1 |
| InChI | InChI=1S/C31H23F3N4O/c1-37-28(22-10-14-25(39-2)15-11-22)29(23-8-12-24(13-9-23)31(32,33)34)38-30(37)26(20-16-18-35-19-17-20)27(36-38)21-6-4-3-5-7-21/h3-19H,1-2H3 |
| InChIKey | ZJCBRFNIGXLISY-UHFFFAOYSA-N |
| XLogP | 7.76 |
| TPSA | 44.35 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 524.55 |
| LogP ≤ 5 | 7.76 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118710919 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.